Leadership, Planning and Evaluation

领导、规划和评估

• 批准号: 10228650
• 负责人: Edward Chu
• 金额: $ 33.62万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-06-01 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10228650
• 关键词: Address; Advisory Committees; Albert Einstein Cancer Center; Appointment; Basic Science; Cancer Center; Cancer Center Support Grant; Clinical; Clinical Research; Clinical Services; Committee Members; Community Outreach; Comprehensive Cancer Center; Consult; Department chair; Development; Doctor of Philosophy; Effectiveness; Elements; Evaluation; Faculty Recruitment; Fostering; Funding; Goals; Health; Infrastructure; Laboratory Research; Leadership; Mission; Ownership; Pilot Projects; Play; Population Sciences; Positioning Attribute; Prevention; Process; Program Evaluation; Recommendation; Reporting; Research; Research Personnel; Resource Sharing; Role; Strategic Planning; Technology; Therapeutic; Translational Research; Translations; Vision; Work; anticancer research; cancer epidemiology; career; college; community engagement; implementation science; meetings; member; organizational structure; population based; programs; recruit

PROJECT SUMMARY - LEADERSHIP, PLANNING AND EVALUATION The AECC senior leadership develops and implements the Center's research mission and goals, as guided by strategic planning and internal and external advisory committees. AECC's senior leadership represent key elements in the research establishment at Einstein with three current and one former department chair, one section chair, and one former program leader. Senior leadership positions that are unchanged since 2013 include the Deputy Director, Roman Perez-Soler, MD, the Associated Director for Laboratory Research, Pamela Stanley, PhD, the Associate Director for Clinical Research, Joseph Sparano, MD, the Associate Director for Population Sciences, Thomas Rohan, MBBS, PhD, the Associate Director for Therapeutics, Susan Horwitz, PhD, the Associate Director for Administration, Richard Seither, PhD, MBA. There are three new senior leadership appointments, the Associate Director for Community Outreach and Engagement, Bruce Rapkin, PhD, and the Associate Director for Cancer Research Career Enhancement, Anne Bresnick, PhD. Dr. Shalom Kalnicki was appointed as Associate Director for Clinical Services (not a CCSG-funded position) to replace Dr. Steven Libutti. The Senior Leadership plays an active and critical role in oversight of all basic, clinical, population-based programs, and in catalyzing transdisciplinary, collaborative, and translational research at the Cancer Center. The Senior Leadership interacts within the context of several key advisory venues: (1) the Executive Committee (all senior leaders) and (2) the Steering Committee (senior leaders, program leaders, and other key AECC members). In addition, the Director's Council, that includes the Director, Deputy Director and Associate Directors for Laboratory Research, Clinical Research and Administration, meets weekly. The Executive Committee is advisory to the Director on Strategic Planning, the ongoing evaluation of programs and shared resources, and the identification of high-priority recruitment and technology needs, selection of External Scientific Advisory Committee (ESAC) members, planning for, and the review of ESAC reports, implementation of ESAC recommendations, the allocation of Developmental Funds for recruitment, pilot projects and the development of new shared resources. The Senior Leadership has played a vital role in guiding the AECC during the period of change in College ownership to Montefiore Health that began shortly after the 2013 CCSG renewal. Beyond the ongoing roles of Senior Leadership in Planning and Evaluation activities, there are three established mechanisms: (i) Formal Strategic Planning, (ii) The External Scientific Advisory Committee, which includes four current and one past director, and two deputy directors of comprehensive cancer centers and (iii) the annual off-campus center-wide retreat “Advances”. A description of these mechanisms for planning and evaluation and their impact is provided.

项目摘要 - 领导，计划和评估 AECC高级领导力发展并实施了中心的研究使命和目标， 战略计划以及内部和外部咨询委员会。 AECC的高级领导代表关键 爱因斯坦研究机构的要素，三位现任和一名前部主席，一名 部门主席和一位前计划负责人。自2013年以来不变的高级领导职位 包括副主任罗马·佩雷斯·塞勒（Roman Perez-Soler），医学博士，实验室研究主管， 帕梅拉·斯坦利（Pamela Stanley）博士，临床研究副主任，约瑟夫·斯帕拉诺（Joseph Sparano），医学博士 人口科学主任，托马斯·罗汉（Thomas Rohan），MBBS，博士，苏珊治疗副总监 Horwitz博士，Richard Seither，博士学位，MBA。有三个新 高级领导任命，社区宣传与参与副主任，布鲁斯 Rapkin博士和癌症研究职业副总监Anne Bresnick博士。博士 Shalom Kalnicki被任命为临床服务副主任（不是CCSG资助的职位） 取代史蒂文·利布蒂（Steven Libutti）博士。高级领导在对所有基本的监督中扮演着积极而关键的角色， 临床，基于人群的计划以及催化跨学科，协作和翻译 癌症中心的研究。高级领导在几个关键咨询的背景下进行互动 风险投资：（1）执行委员会（所有高级领导人）和（2）指导委员会（高级领导人， 计划负责人和其他关键AECC成员）。此外，主任理事会，包括董事 临床研究与管理实验室研究副主任兼副主任， 每周。执行委员会是战略规划主任的咨询，持续评估 计划和共享资源，以及高优先招募和技术需求的识别， 选择外部科学咨询委员会（ESAC）成员，计划和审查ESAC 报告，ESAC建议的实施，招募发展资金的分配， 试点项目和开发新的共享资源。高级领导在 在大学所有权变更为蒙特菲奥尔健康期间，指导AECC，不久就开始 在2013年CCSG续订之后。除了高级领导力在计划和评估中的持续角色之外 活动，有三种既定的机制：（i）形式的战略规划，（ii）外部科学 咨询委员会，其中包括四名现任和一名董事，以及两名副董事 综合癌症中心和（iii）年度校外室内范围内撤退“进步”。描述 提供了计划和评估的这些机制及其影响。